HealthQuill Eisai
Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimerā€™s disease and cognitive impairment has been approved in Japan.
Drugs Health Pharma

Japan approves Eisai Co, Biogen Incā€™s Leqembi for Alzheimerā€™sĀ 

HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimerā€™s disease and cognitive impairment has been.

Read More
The USFDA has granted a standard approval for EisaiĀ and Biogen'sĀ Alzheimer injection, Leqembi ā€”the first treatment to secure the traditional approval, paving the way for wider insurance coverage of the drug.
Drugs Health Pharma

USFDA grants green light to Eisai, Biogenā€™s Alzheimerā€™s drug Leqembi

HQ Team July 7, 2023: The USFDA has granted a standard approval for EisaiĀ and Biogen’sĀ Alzheimer injection, Leqembi ā€”the first treatment to secure the.

Read More